OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Efficacy and safety of moderate-intensity statin with ezetimibe combination therapy in patients after percutaneous coronary intervention: a post-hoc analysis of the RACING trial
Jong‐Il Park, Seung‐Jun Lee, Bum‐Kee Hong, et al.
EClinicalMedicine (2023) Vol. 58, pp. 101933-101933
Open Access | Times Cited: 6
Jong‐Il Park, Seung‐Jun Lee, Bum‐Kee Hong, et al.
EClinicalMedicine (2023) Vol. 58, pp. 101933-101933
Open Access | Times Cited: 6
Showing 6 citing articles:
Fixed Combination for the Treatment of Dyslipidaemia
Nicola Ferri, Massimiliano Ruscica, Raúl D. Santos, et al.
Current Atherosclerosis Reports (2023) Vol. 25, Iss. 10, pp. 691-699
Open Access | Times Cited: 12
Nicola Ferri, Massimiliano Ruscica, Raúl D. Santos, et al.
Current Atherosclerosis Reports (2023) Vol. 25, Iss. 10, pp. 691-699
Open Access | Times Cited: 12
Research trends in lipid-lowering therapies for coronary heart disease combined with hyperlipidemia: a bibliometric study and visual analysis
Quankai Cheng, Jingjing Sun, Haicheng Zhong, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 3
Quankai Cheng, Jingjing Sun, Haicheng Zhong, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 3
Safety and Effectiveness of High‐Intensity Statins Versus Low/Moderate‐Intensity Statins Plus Ezetimibe in Patients With Atherosclerotic Cardiovascular Disease for Reaching LDL‐C Goals: A Systematic Review and Meta‐Analysis
Hamidreza Soleimani, Asma Mousavi, Shayan Shojaei, et al.
Clinical Cardiology (2024) Vol. 47, Iss. 8
Open Access | Times Cited: 2
Hamidreza Soleimani, Asma Mousavi, Shayan Shojaei, et al.
Clinical Cardiology (2024) Vol. 47, Iss. 8
Open Access | Times Cited: 2
Combination therapy with moderate-intensity atorvastatin and ezetimibe versus high-intensity atorvastatin monotherapy in patients treated with percutaneous coronary intervention in practice: assessing RACING generalizability
Seung‐Jun Lee, Jae Hong Joo, Sohee Park, et al.
European Heart Journal - Cardiovascular Pharmacotherapy (2023)
Closed Access | Times Cited: 5
Seung‐Jun Lee, Jae Hong Joo, Sohee Park, et al.
European Heart Journal - Cardiovascular Pharmacotherapy (2023)
Closed Access | Times Cited: 5
Are We Using Ezetimibe As Much As We Should?
Antonis A. Manolis, Theodora A. Manolis, Dimitri P. Mikhailidis, et al.
Biomarker Insights (2024) Vol. 19
Open Access | Times Cited: 1
Antonis A. Manolis, Theodora A. Manolis, Dimitri P. Mikhailidis, et al.
Biomarker Insights (2024) Vol. 19
Open Access | Times Cited: 1
Moderate-Intensity Statin Plus Ezetimibe: Time to Rethink it as an Optimal Initial Lipid-Lowering Strategy
Sha Li, Huihui Liu, Jian‐Jun Li
Drugs (2024) Vol. 85, Iss. 1, pp. 51-65
Open Access
Sha Li, Huihui Liu, Jian‐Jun Li
Drugs (2024) Vol. 85, Iss. 1, pp. 51-65
Open Access
